Although it is universally accepted that dopamine transporters (DATs) exist in monomers, dimers and tetramers (i.e. dimers of dimers), it is not known whether the oligomeric organization of DAT is a prerequisite for its ability to take up dopamine (DA), or whether each DAT protomer, the subunit of quaternary structure, functions independently in terms of DA translocation. In this study, copper phenanthroline (CuP) was used to selectively target surface DAT: increasing concentrations of CuP gradually cross-linked natural DAT dimers in LLC-PK 1 cells stably expressing hDAT and thereby reduced DA uptake functionality until all surface DATs were inactivated. DATs that were not cross-linked by CuP showed normal DA uptake with DA K m at~0.5 lM and DA efflux with basal and amphetamine-induced DA efflux as much as control values. The cocaine analog 2b-carbomethoxy-3b-[4-fluorophenyl]-tropane (CFT) was capable to bind to coppercross-linked DATs, albeit with an affinity more than fivefold decreased (K d of CFT = 109 nM after cross-linking vs 19 nM before). A kinetic analysis is offered describing the changing amounts of dimers and monomers with increasing [CuP], allowing the estimation of dimer functional activity compared with a DAT monomer. Consonant with previous conclusions for serotonin transporter and NET that only one protomer of an oligomer is active at the time, the present data indicated a functional activity of the DAT dimer of 0.74 relative to a monomer.
It is unequivocally accepted that dopamine transporters (DATs) exist in quaternary assemblies as indicated by studies with radiation inactivation (Berger et al. 1994; Milner et al. 1994) , co-immunoprecipitation and cross-linking (Hastrup et al. 2001 (Hastrup et al. , 2003 Chen and Reith 2008) , Ni 2+ chromatography (Torres et al. 2003) and F€ orster Resonance Energy Transfer (Sorkina et al. 2003) . Observations on the ability of amphetamine to dissociate DAT oligomers have been interpreted in the context of a model of an equilibrium between DAT monomers and oligomers at the membrane surface (Chen and Reith 2008; Li et al. 2010) . For the related serotonin transporter (SERT), the co-existence of different degrees of oligomerization at the cell surface has been shown by Anderluh et al. (2014a,b) . In the case of DAT, evidence suggests its quaternization into tetramers or dimers of dimers (Hastrup et al. 2001 (Hastrup et al. , 2003 . Our previous study demonstrated an influence of DAT protomer composition on the properties of a DAT inhibitor (Zhen et al. 2015) . When DAT oligomers contained combinations of certain protomers with differential affinity for the cocaine phenyltropane analog CFT ((-)-2-bcarbomethoxy-3-b-(4-fluorophenyl) tropane = WIN 35 428), the resulting binding affinity differed from that found under conditions where heterooligomers were not present. Despite this knowledge regarding cooperativity for inhibitor affinity, we do not know whether the tetrameric/dimeric organization of DAT is a prerequisite for its ability to take up DA, or whether each DAT protomer functions independently in terms of the DA translocation process itself. In the following, monomers that are combined to form an oligomer will be referred to as protomers. Do the functional uptake properties of monomers differ from those of oligomers, i.e. are DA uptake facilitated by combining protomers in a quaternary complex, are protomers simply functioning equally active when combined in an oligomer, or is their activity hindered by the presence of neighboring protomers in the quaternary structure? In order to begin addressing this question, we searched for a tool to affect the equilibrium between DAT monomers and oligomers at the cell surface and a method of analysis allowing an estimate of the activity of an oligomer compared with that of a monomer. Although amphetamine appears to affect the equilibrium between monomers and oligomers, it cannot be used in functional experiments as it itself affects the uptake process. We present evidence here that copper phenanthroline (CuP) can be such a tool, selectively targeting surface DAT. In addition, we lay out a novel kinetic analysis providing an estimate of the DA uptake activity of oligomerized DAT in comparison to monomeric DAT.
Materials and methods
Cell culture and cell culture plates coating Lewis lung carcinoma-porcine kidney (LLC-PK 1 ) were stably transfected with the human dopamine transporter (hDAT)-WT and P554L maintained in minimum essential medium supplemented with 10% fetal bovine serum and 2 mM L-glutamine in a cell culture incubator gassed with 5% CO 2 at 37°C. Sl cell lines were generated with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) transfection reagent used with manufacturer's suggested amount of the appropriate plasmid, selected with 800 lg/mL geneticin (G418) and maintained with 200 lg/mL G418 as selection pressure.
Some experiments included the glycosylation-deficient stable cell line HEK-M 3 which was prepared previously by us (Li et al. 2004) ; for protein sequence, see details therein). HEK-M 3 cells are human embryonic kidney cells (HEK293, ATCC CRL1573) carrying the triple mutations N181Q, N188Q and N205Q, which has all of the three putative N-linked glycosylation sites in human DAT removed. HEK-WT and HEK-M 3 were cultured in Dulbecco's modified Eagle medium supplemented with 10% fetal bovine serum, 2 mM Lglutamine and 200 lg/mL G418.
One of the cell lines we used in this manuscript, HEK293 (RRID: CVCL_0045), is listed as a commonly misidentified cell line (ICLAC; http://iclac.org/datanases/cross-contaminations). It is commonly misidentified with the Hela cell line. We bought HEK293 from an entrusted source (ATCC) and had no Hela cultures in our lab. Furthermore, in this work, HEK293 cells are only used for showing the different penetration pattern of permeable and nonpermeable cross-linkers in cells stably transfected with a glycosylation-deficient DAT (for protein sequence of this M3 cell line, see Li et al. 2004) . The majority of the present work was carried out with LLC-PK 1 cells (RRID: CVCL_0391), which are not on the list of commonly misidentified cell lines. The scientific justification for using HEK293 and LLC-PK1 cells in this work was the ease of comparing the present functional results to those published by many other investigators for DAT expressing HEK293 and LLC-PK1 cells.
To enhance the adherent ability of HEK293 cells to cell culture plate surface during the following procedures involving multiple washings, we coated the cell culture plates with AB-30 polymer (Bledi et al. 2000; Chi and Reith 2003) before seeding cells onto them. All cells -HEK293 and LLC-PK 1 -were grown to $ 80% confluence in variously sized culture plates prior to experimentation.
Cross-linking of surface and intracellular hDAT with CuP and bis (maleimido)ethane (BMOE) Cells were cultured in 60 mm cell culture Petri dishes and quickly washed with DPBS (Dulbecco's phosphate-buffered saline without calcium and magnesium). The cross-linking protocol with CuP (mixture of CuSO 4 with 1,10-phenanthroline) was as described in our previous work (Li et al. 2004; Chen and Reith 2008) . Briefly, to each dish, 3 mL of 100 lM CuP (100 lM CuSO 4 and 400 lM 1,10-phenanthroline in DPBS) cross-linking buffer was added and incubated for 5 min at 21°C with gentle shaking.
BMOE (Thermo scientific, Rockford, IL, USA) is a short-arm and membrane-permeable bismaleimide cross-linker for conjugation between sulfhydryl groups (-SH). A quantity of 25 mM BMOE was prepared freshly in 100% dimethylsulfoxide and diluted to the final concentration of 0.25 mM with cold phosphate-buffered saline (PBS) just before the assay. Cells growing in 60 mm Petri dishes were washed with cold DPBS three times and, after addition of 3 mL of 0.25 mM BMOE in PBS, kept for 1 h at 4°C.
After treatment with CuP and BMOE, cells in Petri dishes were rinsed with DPBS twice and incubated with 10 mM N-ethylmaleimide (NEM) in PBS to quench CuP or 10 mM cysteine in PBS to quench BMOE for 20 min at 21°C, followed by three more washes. The Petri dishes were placed on ice and assayed for surface hDAT by biotinylation.
Assessment of cytoplasmic hDAT with biotinylation
Surface fraction was characterized with the biotinylation procedure as described in our previous publication (Li et al. 2010) . Briefly, cells were incubated with 1 mg/mL sulfo-NHS-SS-biotin (Thermo Scientific, Rockford, IL, USA) in cold DPBS-CM (DPBS supplemented with 1 mM MgCl 2 and 0.1 mM CaCl 2 ) for 60 min at 4°C. The reaction was quenched by replacing biotin-DPBS-CM buffer with PBS-100 mM glycine buffer and further incubation for 20 min. After extensive wash, cells were lysed in NP40 (50 mM Tris, 150 mM NaCl and 1% Triton X-100, PH = 8.0) supplemented with a protease inhibitor cocktail (Thermo Scientific, Waltham, MA, USA) for 60 min on ice with vortexing 10 s every 5 min. The lysate was centrifuged at 14 000 g for 20 min at 4°C and the supernatant was for separation of biotinylated proteins with excess of immobilized monomeric NeutraAvidin beads (Thermo Scientific, Waltham, MA, USA). The wash-out fraction, i.e. the unbiotinylated lystate is the cytoplasmic fraction, collected from the supernatant as described (Kilic and Rudnick 2000; Zhu et al. 2005; Holman and Henley 2007) . The cytoplasmic fraction and total lysate were analyzed by western blotting. Polyclonal anti-DAT antibody against the Nterminal of DAT (RRID: AB_1586991) were used (Millipore Sigma, St. Louis, MO, USA), followed by horseradish peroxidaseconjugated goat anti-rabbit antibody; Polyclonal anti-b-actin antibody (Sigma-Aldrich, St. Louis, MO, USA) was used as a loading control. The transporter signal was visualized using Thermo Scientific SuperSignal West Pico Chemiluminescent Substrate solution (Thermo Scientific, Waltham, MA, USA) and analyzed with Image J software (downloaded from NIH). The integrated density values (IDV) of DAT dimers and total DAT in the whole cell lysates, yielded with Image J, were used to calculate the presence of DAT dimer (dimer % = dimer IDV/total DAT IDV 9 100). (Liang et al. 2009; Schmitt and Reith 2011) . Increasing concentrations of nonradioactive CFT were included in the assay mixture to generate final CFT concentrations of 1, 3, 10, 30, 100 or 300 nM. Non-specific binding was defined with 1 lM CFT. A Biorad-DC protein kit was used to determine the cellular protein level. H]DA (48 Ci/mmole, Perkin Elmer, Boston, MA, USA) was added for a final concentration of 5 nM onto 24-well cell culture plates and incubation continued for 5 min at 21°C. The uptake assay was stopped by aspirating off the supernatant, and cells were subjected to quick washing (three times) with cold PBS. Cold 5% trichoroacetic acid (50 lL per well) was added to cell culture plate wells to lyse cells at 4°C for 30 min and supernatant was collected into 24-well flexible plates and counted in 500 lL of scintillation cocktail. The Biorad-DC protein kit was used to determine the cellular protein level.
In the experiments in which cells were treated with copper and recovery of DAT function by zinc ion was measured, copper treatment was with 10 lM CuP, i.e. 10 lM CuSO 4 and 40 lM 1,10 phenanthroline. After pre-treatment with 10 lM CuP for 5 min at 21°C and following thorough washes with DPBS, various concentrations of ZnCl 2 were added into wells for a 15-min incubation before carrying out the [ 3 H]DA uptake assay. To ensure the effect of Zn 2+ , unlabeled and radiolabeled dopamine solutions were added directly to Zn 2+ containing wells in the 24-well plate. To quantify the effect of Zn 2+ on DAT function, the result was expressed as the percentage of hDAT activity in the absence of both ZnCl 2 and CuP for both CuP-treated and control groups. , and differences between two groups were analyzed with the Student's ttest (Microsoft Excel 2010); Significance is indicated by two-tailed p < 0.05. Distributions were tested for normality (by method of Kolmogorov and Smirnov), with data distributions meeting this assumption for group difference testing. ANOVA (which addresses false positives in multiple group difference testing) did not show group differences, and therefore subgroup interactions were not further examined. The assumption for ANOVA is that data are sampled from populations with identical standard deviations, but the commonly used method of Bartlett can only be used when n is at least 5 (in Tables 1 and 2 n was 3-4). Outlying values were not encountered in this study as defined by any value that would generate a non-Gaussian distribution for the data sample studied.
Results were expressed as the mean AE SE averaged from at least three independent experiments (n); n denotes an observation made in triplicate with an independent cell preparation (from the same source of cells) studied on the day of the experiment (see tables and figures for n values of reported experiments). Sample sizes used in this study were based on a similar study design we used in our previous study on this topic (Zhen et al. 2015) . In this in vitro study, confounding variables, i.e. variables that could affect the outcome of the measured dependent variable as a function of the independent variable, were minimized by standardizing all aspects of the protocol, such as length of time of cell culturing to cell confluency; conditions (time, temperature) for cross-linking, biotinylation and trypsinization; and consistent use of a given chemical from the same source throughout all experiments.
The DNA work in this project was approved by the Environmental Health and Safety Committee of New York University School of Medicine on Jan 17,/2017, Biosafety Level 2 (BSL2) protocol IBC 16-000001.
The general concept of this study was reported in our grant application to the National Institutes of Health (USA), but the specific study design per se was not pre-registered. For outcomes, the authors did not have pre-specified endpoints: the study was exploratory.
In preparing the present work for publication, the guide for ethical behavior in publishing research was followed as described in the COPE Report 2003 [available from the Committee on Publication Ethics (COPE)].
Results
Comparison of a membrane-permeable and -impermeable cross-linker Cross-linking WT-DAT in LLC-PK 1 cells with CuP produced only dimers (~180 kDa) in addition to monomers (~80 kDa) and immature DAT (~55 kDa) when measured in total lysates (Fig. 1a lane 3 , note the lack of dimers in the absence of CuP, lane 1); the lack of higher-order oligomers (more than dimer) observed with CuP agrees with previous studies (Hastrup et al. 2001; Chen and Reith 2008) . However, dimers were notably absent from cytoplasmic lysates with CuP ( Fig. 1b  lanes 1 and 3) , indicating CuP did not reach intracellular DATs. In contrast, cross-linking with membrane-permeable bismaleimidoethane (BMOE) that has a short (~8 A) spacer arm for covalently connecting sulfhydryl groups, produced dimers and higher-order oligomers in both total and cytoplasmic lysates (Fig. 1a lane 2 and Fig. 1b lane 2) . During this work, we noticed that the detergent Triton X-100 and/or the treatment with cross-link reagents interfere with the DC protein (Bio-Rad Laboratories, Hercules, CA, USA) quantitation assay, especially with the microplate protocol; therefore, we could not compare the bands directly among the treatments considering the uncertainty regarding equal loading of the different gels. However, we were able to examine the percent of dimer among all populations of DAT protein (taking into account total DAT IDV yielding the DAT Dimer %), a measure which is not affected by the loading amount, enabling comparisons among groups.
P554L is a missense human DAT mutation identified in a clinical syndrome, dopamine transporter deficiency syndrome and is devoid of glycosylation (Kurian et al. 2011 ). In total cell lysate, there was only immature DAT without crosslinker ( Fig. 1a lane 4) , an apparent dimer (~120 kDa) in the CuP-treated group (lane 5) and additional higher-order oligomers in the BMOE-treated group (lanes 6). In cytoplasmic lysates (Fig. 1b) , the densities were considerably lower because of the smaller correction made for P554L's low expression in terms of protein applied to the gel; nevertheless, the absence of dimers with CuP treatment and the presence of higher-order material with BMOE treatment again suggested penetration into cells of BMOE but not CuP.
A very similar set of observations applies to HEK293-M 3 (Fig 1a and b, lanes 10-12) , a DAT construct incapable of glycosylation because of the lack of the three consensus glycosylation sites (Li et al. 2004) . Note that for these experiments WT results are shown for HEK293 cells (lanes 7-9) because the stably expressing M 3 cells were of the HEK293 cells (Li et al. 2004) .
The results taken together support the use of CuP in targeting selectively DAT at the membrane surface.
Distribution of DAT over cell surface and interior DAT distributes between the cell plasma surface and interior cytoplasm, enabling a difference in action between a membrane-impermeable and membrane-permeable cross- linkers. Indeed, WT-DAT immunoreactivity was observed throughout the cell and surface in confocal images (Fig. 2a) . In contrast, P554L DAT immunoreactivity was seen predominantly internally (Fig. 2d) with a pattern very similar to that seen for the intracellular ER marker calnexin ( Fig. 2b  and e) , showing extensive overlap with the intracellular ER marker calnexin reactivity (Fig. 2f) as opposed to that between WT-DAT immunoreactivity and calnexin (Fig. 2e) .
Treatment of WT-DAT with increasing concentrations of CuP As concentrations of CuP increased starting with 1 lM, DA uptake diminished progressively, with 100 lM CuP almost eliminating DA uptake completely (Fig. 3 dashed red curve) . The routinely applied three washes were sufficient to remove CuP, which therefore had no effect in the following uptake assays (Fig. 3 inset) .
The amount of dimers (% dimer), expressed as percent of total DAT found in total cell lysate progressively increased with increasing CuP concentrations (dashed black curve). The highest % dimer we observed was 64%, corresponding to where the specific DA uptake activity was near zero. If we assume that Cu 2+ -linked dimers are incapable of DA uptake and reason that increasing Cu 2+ ultimately would inactivate all surface DATs, we come to the conclusion that the 64% value is the percentage of cell surface DAT in total lysate of LLC-PK 1 -hDAT cells. In HEK293-hDAT cells, our observations indicated that approximately 54% of total DAT resided at the surface (Chi and Reith 2003) ; in PC 12 -hDAT cells this value ranged between 40 and 47% depending on DAT expression (Loder and Melikian 2003) . Because of the reasonable agreement between the reported values of surface presence of DAT and the value predicted under the assumption that Cu 2+ -linked dimers are functionally inactive, we propose we can use CuP as a tool for inactivating DAT selectively at the surface.
Properties of WT-DAT measured after exposure to CuP
In agreement with earlier reports, increasing concentrations of Zn 2+ gradually decreased [ 3 H]DA uptake (Fig. 4 black  solid line) . A similar curve for Zn 2+ inhibition was observed after treatment of 10 lM CuP, but at overall lower levels of uptake activity (red curve). This is consonant with the finding that the remaining active DATs that are not linked by Cu 2+ after 10 lM CuP treatment responded to Zn 2+ in the same way as DATs in preparations never exposed to CuP. Also, the V max of DA uptake was decreased by 10 lM CuP (p = 0.01) without a change in K m ( Relationship between DA uptake activity and presence of DAT dimers In Fig. 5 , the [ 3 H]DA uptake activity is plotted as a function of the presence of DAT dimers expressed as percent of total DAT in total lysates (gel dimer IDV/total DAT IDV 9 100, in which IDV denotes integrated density value) obtained with varying CuP concentrations in the same experiments as shown in Fig. 3 . The results indicate a progressive loss of uptake as more DAT dimers are inactivated by CuP, with the value of dimer % reaching a maximum of 64%.
The equilibrium between dimers (D) and monomers (M) at cell surface plasma is given by D , 2 + M (See Supporting Information). This allows for a calculation of fractions of natural dimers and monomers with K set at 0.001, 0.1, 1, 10 and 100 (see Table S2 ). The observed [ 3 H] DA uptake activity in our experiments is the sum of activities contributed by dimer and monomer as follows: Table S3 shows the full calculations of the activity of the dimer as a function of that of the monomer under values of K of 0.001, 0.1, 1, 10 and 100. For K = 0.001, 0.01 and 0.1, the dimer activities varied greatly depending on applied CuP concentrations with SE values exceeding 30% of the mean activity under a given K, indicating a considerable deviation between observed results and the model tested. However, dimer activities became more consistent across CuP concentrations when K was 1, 10 or 100, with SE values dropping to 10% (Table S3; see also Tables S1 and S2 for calculation of dimer and monomer populations across the entire range of nine CuP concentrations). Summarized results for populations and dimer activities under K values of 1, 10 or 100, for just three CuP concentrations are shown in Table 3 . It can be seen that for K = 1, 10 and 100, dimers are always more abundant than monomers (until increasing CuP concentrations have inactivated all DAT). Importantly, the functional activity of a dimer is considerably less than the sum of two monomers as indicated by Fd values of 0.70 AE 0.1, 0.74 AE 0.08 and 0.74 AE 0.08, respectively (Table 3) . If only one protomer in a dimer is active at the time, the Fd values would be 1.0 (for comparison, if the dimer consists of two fully active protomers Fd would be 2.0). Extensive overlap is seen between hDAT-P554L and ER marker while little overlap between hDAT-WT and ER marker occurs.
Discussion
Relationship between oligomerization, glycosylation and subcellular distribution of DAT There is evidence that oligomerization and glycosylation of biogenic amine transporters are intimately linked, but there is contrasting evidence as to which comes first in maturation of the transporter as it moves from nucleus to endoplasmic reticulum (ER) to Golgi to surface (Ozaslan et al. 2003; Torres et al. 2003) . N-linked glycosylation [the type of glycosylation of DAT (Patel and Reith 2002) ] with highmannose glycans occurs in ER, followed by trimming of glucose and mannose in ER and cis Golgi (Li et al. 2007; Huang et al. 2008) . Then, in Golgi, there is addition of Nacetylglucosamine, galactose and sialic acid. A seminal paper by Torres et al. (2003) showed that a DAT mutant lacking the leucine repeat from TM2 (termed TM24LA), while itself defective in DA uptake, fails to interact with wild-type DAT to form oligomers, does not show expression at the cell surface, and is not glycosylated (Torres et al. 2003) . Along with evidence by us (Li et al. 2004 ) and others (Torres et al. 2003 ) that lack of glycosylation itself only partially reduces trafficking of DAT to the membrane surface, the results for TM24LA suggest that assembly of DAT into oligomers in ER precedes glycosylation of the transporter, and, thus, lack of assembly in TM24LA results in lack of glycosylation. A somewhat different situation is presented by the current findings for P554L and M 3 : both constructs appear to be able to form oligomers as shown by Cu 2+ linking, but lack any glycosylation (see Fig. 1 ). However, these results again demonstrate that glycosylation is not a prerequisite for oligomerization of DAT, and the data are consonant with oligomerization preceding glycosylation. Most likely, the unglycosylated oligomers distribute to the cell surface less efficiently, as shown by confocal microscopy both for P554L (Fig. 2) and M 3 (Li et al. 2004 ). The situation may be different for SERT: the group of Kilic (Ozaslan et al. 2003) reported that SERT either devoid of N-acetylglucosamine and complex glycosylation, or devoid of any glycosylation entirely, was not capable of oligomerization, suggesting that glycosylation may contribute to correct folding of SERT (as it does in many other proteins (Patel and Reith 2002) ) and to oligomer formation. Furthermore, in the same study (Ozaslan et al. 2003) , unglycosylated SERT, which could not form oligomers, reached the surface as well as fully glycosylated SERT, indicating that monomers and oligomers were equally capable of inserting themselves into the membrane. This contrasts with the situation for DAT, which is generally believed to be inserted into the plasma membrane in oligomer form (Torres et al. 2003; Sitte et al. 2004; Li et al. 2010) . All of this suggests that DAT and SERT are basically different in their relationship between oligomerization, glycosylation and trafficking. This may also apply to the subcellular localization of equilibration between monomers and oligomers, whereas we interpreted effects of amphetamine on DAT oligomers in the context of such an equilibrium occurring at the cell surface (Chen and Reith 2008) , recent findings for SERT point to the endoplasmic reticulum as the site of equilibration with ratios between monomers and oligomer species being rather fixed at the surface (Anderluh et al. 2017) .
Functional activity of copper-linked DAT oligomers
Increasing concentrations of CuP progressively reduced DA uptake activity, suggesting that Cu 2+ linking sulfhydryl groups at the dimer interface in the human DAT actually inactivated its DA uptake activity (Fig. 3) . Hastrup et al. (2001) reported that cross-linking DAT with Cu 2+ had little or no effect in inhibiting uptake of the substrate tyramine. One difference between this report and the current study is the DAT construct used: hemagglutinin (HA)-tagged WT-DAT (Hastrup et al. 2001) versus untagged WT-DAT (present experiments) . The HA tag replaced the first 22 Nterminal residues. In the case of SERT, the N-terminus has been proposed to function as a lever in reversed transport (Sucic et al. 2010) ; possibly the conformation of this region of DAT is altered when it takes the form of a Cu 2+ -linked oligomer, a change that perhaps cannot happen when HA replaces the first 22 amino acids of the N-terminus. Another possibility is that in the Hastrup et al. (2001) study there was a change in uptake that was not captured by only measuring uptake at one fixed concentration of the substrate tyramine: no information was reported on the effect of Cu 2+ on the K m or V max of tyramine uptake. Nevertheless, inhibition of DAT function by Cu 2+ cross-linking fits in with results reported by Norgaard-Nielsen et al. (2002) . In this work, the Gether group first removed high-affinity binding of Zn 2+ from DAT by mutating H193, one of the three residues coordinating Zn 2+ (the other two being H375 and E396), and then generated a novel Zn 2+ -binding site consisting of an histidine inserted at position 310 and naturally occurring C306. Tables S2 and S3.   b Values shown were computed as in Table S3 from results obtained at all nine concentrations of CuP. Fig. 5 The relationship between DAT uptake activity and the dimer fraction of hDAT. LLC-PK 1 cells stably expressing hDAT-WT were cross-linked with various concentrations of CuP for 5 min at 21°. In parallel, western blot analysis was done on the whole cell lysate from the treated LLC-PK1 cells and specific [
3 H]DA uptake activity was determined. DAT dimer is expressed as the fraction (IDV %) of the sum of dimeric DAT, monomeric DAT and immature DAT. Additional experiments showed that Zn 2+ bound to H310 and C306 within one and the same DAT protomer, thereby disturbing conformational changes occurring upon substrate translocation in transmembrane domain 6, a predicted dimeric interface (Norgaard-Nielsen et al. 2002) . In light of the strong inhibitory effect on function by Zn 2+ acting in the dimeric interface, it may not be surprising that Cu 2+ acting in this region (as a cross-linker) is also strongly inhibitory as we propose based on the results obtained in the present study.
Activity of monomers by themselves versus protomers assembled in oligomers of DAT All studies with biogenic amine transporters point to their quaternary assembly into oligomers (Berger et al. 1994; Milner et al. 1994; Hastrup et al. 2001 Hastrup et al. , 2003 Schmid et al. 2001; Sitte and Freissmuth 2003; Sorkina et al. 2003; Just et al. 2004; Sitte et al. 2004; Chen and Reith 2008; Li et al. 2010) . Available evidence suggests that DAT, as SERT, is a tetramer Milner et al. 1994; Hastrup et al. 2003) . Our working model for DAT is that interactions between protomers occur within each of the two dimers in the tetramer. Our previous work indicated cooperativity within the DAT oligomer with respect to inhibitor affinity (Zhen et al. 2015) , but there is to our knowledge no information regarding functional cooperativity for substrate translocation in any biogenic amine transporter. Although dominantnegative effects occur with one inactive mutant protomer incapacitating the entire DAT oligomer (Torres et al. 2003) , this could be a special effect related to mutation-induced functional changes, and does not necessarily provide information regarding natural DAT oligomers. In contrast, in the present experiments DAT protomers are wild-type transporters, with varying concentrations of monomers in equilibrium with dimers allowing a comparison of monomer and dimer activity. Our findings indicate that the dimer is appreciably less active than the sum of two normally active monomers; in fact, the estimated F d value of 0.74 is consonant with two protomers each functioning at 37% of the normal monomer activity, or any other combination that gives a total sum of 74% for the dimer (percent of one monomer's activity). For example, in the dimer one protomer could be totally inactive, with the other protomer functioning at 74% of monomer value. In this context, it is important to recall that it has been suggested for SERT and norepinephrine transporter (NET) that only one protomer is active at the time, i.e. activity in one shuts down the other Kocabas et al. 2003; Larsen et al. 2011) . In a recent paper by Cheng et al. (2017) , some (but not all) DAT dimers in an in silico molecular dynamics study displayed coupled conformational transitions in the protomers. It suggests the possibility that transitions needed for substrate translocation can happen in conjunction in two protomers forming the DAT dimer. Applied to our findings, it would suggest that the two protomers in a DAT dimer function in tandem at 37% of the normal DAT monomer activity. However, because the findings of Cheng et al. (2017) did not apply to all DAT dimers observed by molecular dynamics, and because there is strong biochemical evidence for SERT and NET protomers shutting down the associated protomer in the respective dimer Kocabas et al. 2003; Larsen et al. 2011) , we favor the interpretation of our DAT data that has one protomer being active at the time.
Conclusion
The present results indicate that the non-penetrating crosslinker CuP inactivates the DA uptake activity of DAT dimers by cross-linking them. Kinetic analysis of varying concentrations of DAT monomer and dimer supports the conclusion that in the DAT dimer only one protomer is active at the time, working at slightly diminished level, only 74% of a DAT monomer. However, we cannot be certain that our method is precise enough to pinpoint this additional reduction in activity on top of the inactivity of the protomer that is linked to the one which is translocating substrate.
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